Resumo
鉴别诊断
常见
- Induzida por bebidas alcoólicas
- Esteatose hepática
- Colangite biliar primária (CBP)
- Colangite esclerosante primária
- Hemocromatose
- Linfoma de Hodgkin
- Linfoma não Hodgkin (LNH)
- Macroglobulinemia de Waldenström ou linfoma linfoplasmacítico
- Leucemia mieloide aguda (LMA)
- Leucemia mieloide crônica (LMC)
- Leucemia linfoide aguda (LLA)
- Leucemia linfocítica crônica (LLC)
- Leucemia de células pilosas
- Mielofibrose
- Policitemia vera
- Trombocitose essencial
- Metástases esplênicas
- Anemia hemolítica autoimune
- Artrite reumatoide (AR)
- Síndrome de Felty
- Lúpus eritematoso sistêmico
- Sarcoidose
- Malária
- Vírus Epstein-Barr (EBV)
- Endocardite
- Abscessos esplênicos relacionados à sepse
- Hepatite C crônica
- Hepatite B crônica
- Anemia falciforme
- Defeitos citoesqueléticos
- Talassemias
不常见
- Tumores esplênicos benignos
- Trombose da veia porta
- Trombose da veia esplênica
- Síndrome de Budd-Chiari
- Linfo-histiocitose hemofagocítica (LHH)
- Amiloidose
- Doença de Gaucher ou de Niemann-Pick
- Dengue grave
- Ruptura esplênica
- Hemorragia subcapsular
- Secundária ao fator estimulador de colônias de granulócitos (G-CSF)
撰稿人
作者
Terri L. Parker, MD
Assistant Professor of Medicine
Section of Hematology
Yale School of Medicine
Smilow Cancer Center at Yale-New Haven
New Haven
CT
利益声明
TLP declares that she has no competing interests.
鸣谢
Dr Terri L. Parker would like to gratefully acknowledge Dr Alan E. Lichtin, the previous contributor to this monograph.
利益声明
AEL has received research support from Amgen.
同行评议者
Priyanka Mehta, MD
Consultant Haematologist
Bristol Haematology and Oncology Centre
Bristol
UK
Disclosures
PM declares that she has no competing interests.
Ruben A. Mesa, MD
Professor of Medicine
Mayo Clinic
Scottsdale
AZ
Disclosures
RAM declares that he has no competing interests.
Giovanni Barosi, MD
Director of the Laboratory of Clinical Epidemiology
IRCCS Policlinico S. Matteo Foundation
Pavia
Italy
Disclosures
GB declares that he has no competing interests.
Guidelines
- Haematolymphoid tumours: WHO classification of tumours, 5th edition, volume 11
- Points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
More GuidelinesPatient information
Hepatitis B: should I have the vaccine?
Hepatitis C: what is it?
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer